Campbell's
CPB
$21.38
-3.37%
The Campbell's Company is a leading domestic packaged food manufacturer with a portfolio spanning iconic brands such as Campbell's soups, Pepperidge Farm, Goldfish, Snyder's of Hanover, and Rao's, operating primarily in the U.S. packaged foods industry. As a market leader in soup and a significant player in snacks and simple meals, the company differentiates itself through a diversified brand portfolio and a strong retail presence. Currently, the investor narrative centers on the company's turnaround efforts, including cost-cutting initiatives and margin repair, following a period of declining revenue, a recent dividend cut, and concerns about its potential removal from the S&P 500 index. Recent news highlights management's focus on stabilizing the business for patient investors, while the stock trades near 52-week lows, reflecting significant market pessimism.…
CPB
Campbell's
$21.38
Related headlines
Investment Opinion: Should I buy CPB Today?
Rating: Hold. The stock is trading at $21.38, near its 52-week low of $19.56, with an average analyst target of $20.85, implying a slight downside. The consensus recommendation is 'Hold' (mean 3.3), reflecting uncertainty about the turnaround. The thesis is that CPB is a deep-value play with a 7% dividend yield, but the declining revenue and high debt make it a risky hold until evidence of stabilization emerges.
Sign up to view all
CPB 12-Month Price Forecast
The AI assessment leans bearish due to the persistent revenue decline and high debt levels, which overshadow the apparent valuation discount. The forward PE suggests the market expects a sharp earnings recovery, but the fundamental data does not yet support this. If the company shows signs of stabilization in the next two quarters, the stance could upgrade to neutral. Conversely, further deterioration or an S&P 500 removal would reinforce a bearish outlook.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Campbell's's 12-month outlook, with a consensus price target around $20.85 and implied upside of -2.5% versus the current price.
Average Target
$20.85
0 analysts
Implied Upside
-2.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$16 - $42
Analyst target range
The target price range spans from a low of $16.00 to a high of $41.50, representing a wide spread of 159% from low to high, indicating significant uncertainty about the company's future. The low target implies a further decline of 25% from current levels, likely pricing in continued revenue declines and margin pressure, while the high target suggests a potential doubling of the stock, assuming successful turnaround and margin expansion. Recent institutional ratings show a bearish tilt, with actions such as 'Underperform' from B of A Securities and Bernstein, and 'Sell' from UBS, while others maintain neutral stances. This pattern suggests that analysts are cautious, with no recent upgrades, reflecting the challenging fundamental outlook.
Drowning in data?
Find the real signal!
Bulls vs Bears: CPB Investment Factors
The bear case currently holds stronger evidence, driven by declining revenue, high debt, and negative analyst sentiment. The bull case rests on deep value (7% yield, forward PE 10.4x) and potential earnings recovery, but requires successful execution of cost cuts and margin repair. The central tension is whether the company can stabilize revenue and improve margins before financial pressures force further dividend cuts or index removal. If the turnaround gains traction, the stock could re-rate significantly; if not, further downside toward the 52-week low is likely.
Bullish
- Deep Value with 7% Dividend Yield: CPB trades at $21.38, near its 52-week low of $19.56, with a dividend yield of 7.05% (payout ratio 116.6%). This high yield, supported by $898M in TTM free cash flow, offers income investors a rare opportunity, though the payout ratio signals potential dividend pressure.
- Forward PE Suggests Earnings Recovery: The trailing PE is 16.69x, but the forward PE is only 10.37x, implying analysts expect significant EPS growth (to $2.01) in the next year. If achieved, the stock could re-rate higher, offering upside from current levels.
- Iconic Brands and Market Leadership: Campbell's owns leading brands like Campbell's soups, Goldfish, and Rao's, with snacks contributing 43% of FY2025 revenue. This diversification provides a stable base for a potential turnaround, as management focuses on cost cuts and margin repair.
- Positive Free Cash Flow Generation: TTM free cash flow is $898M, providing a cushion for debt reduction and dividend payments. This cash generation supports the company's ability to invest in growth initiatives and stabilize operations.
Bearish
- Revenue Declining Sequentially and YoY: Q3 FY2026 revenue fell 4.4% YoY to $2.366B, with sequential declines from $2.677B in Q1 to $2.564B in Q2. This persistent top-line erosion indicates weak demand across categories, challenging the turnaround narrative.
- High Debt and Low Liquidity: Debt-to-equity is 1.85x, and the current ratio is 0.82, indicating potential liquidity stress. High interest expenses ($83M in Q3) consume cash flow, limiting financial flexibility.
- Dividend Cut and S&P 500 Removal Risk: The recent dividend cut (payout ratio 116.6%) and potential removal from the S&P 500 (market cap $6.67B) could trigger forced selling by index funds, adding downward pressure on the stock.
- Analyst Sentiment Bearish: Recent ratings include 'Underperform' from BofA and Bernstein, and 'Sell' from UBS, with no upgrades. The average analyst target of $20.85 is below the current price, implying limited upside.
CPB Technical Analysis
The prevailing price trend for Campbell's is a clear downtrend, with the stock down 34.5% over the past year and currently trading at $21.38, near the low end of its 52-week range (between $19.56 and $34.17). The stock is positioned at approximately 18% above its 52-week low and 37% below its 52-week high, indicating that sellers have dominated and the stock remains in a bearish phase. This positioning near lows suggests the market is pricing in significant fundamental deterioration, though it could also present a value opportunity if the company's turnaround gains traction.
Beta
0.02
0.02x market volatility
Max Drawdown
-41.2%
Largest decline past year
52-Week Range
$20-$34
Price range past year
Annual Return
-34.5%
Cumulative gain past year
| Period | CPB Return | S&P 500 |
|---|---|---|
| 1m | -7.2% | -0.4% |
| 3m | -1.4% | +4.2% |
| 6m | -17.1% | +13.7% |
| 1y | -34.5% | +19.0% |
| ytd | -22.8% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CPB Fundamental Analysis
Revenue has been declining, with the most recent quarter (Q3 FY2026, ended May 3, 2026) showing revenue of $2.366 billion, a 4.4% decrease year-over-year. This follows a trend of sequential revenue declines from $2.677 billion in Q1 FY2026 to $2.564 billion in Q2 FY2026, indicating a decelerating top line. The company's revenue segments show baked snacks as the largest at $1.033 billion, followed by beverages at $755 million and soups at $578 million, but the overall decline suggests weakness across categories.
Quarterly Revenue
$2.4B
2026-05
Revenue YoY Growth
-4.4%
YoY Comparison
Gross Margin
27.5%
Latest Quarter
Free Cash Flow
$898000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CPB Overvalued?
Given that Campbell's has positive net income, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 16.69x, while the forward PE is 10.37x, implying that the market expects earnings to grow significantly in the next year. This gap suggests that analysts anticipate a substantial recovery in profitability, likely driven by cost-cutting and margin improvement initiatives.
PE
16.7x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 12x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are elevated: revenue declined 4.4% YoY in Q3 FY2026, with sequential drops from $2.677B to $2.366B, indicating deteriorating demand. The company carries a high debt-to-equity ratio of 1.85x, and interest expenses of $83M per quarter consume a significant portion of operating income. The dividend payout ratio of 116.6% exceeds 100%, meaning the company is paying out more than it earns, a clear red flag that led to the recent dividend cut. Liquidity is tight with a current ratio of 0.82, suggesting potential difficulty meeting short-term obligations. Free cash flow of $898M provides some buffer, but if revenue declines persist, cash generation could weaken, straining debt servicing and dividend sustainability.
FAQ
The key risks are: 1) Financial risk: high debt-to-equity of 1.85x and a current ratio of 0.82, which could lead to liquidity issues. 2) Dividend risk: the payout ratio of 116.6% and recent dividend cut indicate potential for further cuts. 3) Market risk: the stock is down 34.5% over the past year, and if removed from the S&P 500, forced selling could drive the price lower. 4) Operational risk: revenue is declining 4.4% YoY, and if the trend continues, margins and cash flow will suffer. The most severe risk is a combination of these factors leading to a downward spiral.
The 12-month forecast is uncertain, with a base case probability of 50% for the stock to trade between $20 and $23, aligning with the average analyst target of $20.85. The bull case (25% probability) sees the stock at $25-$30 if the turnaround succeeds, while the bear case (25% probability) could push it to $16-$19 if revenue declines accelerate. The most likely scenario is continued stagnation with modest downside, as the company works through its challenges. Investors should watch for signs of revenue stabilization and margin improvement to reassess the outlook.
On a trailing PE basis of 16.69x, CPB appears fairly valued relative to its historical average, but the forward PE of 10.37x suggests the market expects significant earnings growth. The price-to-sales ratio of 0.68x is below the industry average, indicating potential undervaluation. However, the low valuation is justified by the declining revenue and high debt. The market is pricing in a successful turnaround, but if that fails, the stock could be overvalued. Overall, CPB is trading at a discount to its intrinsic value if the earnings recovery materializes, but the risk is high.
CPB is not a clear buy for most investors due to declining revenue and high debt. The stock offers a 7% dividend yield, but the payout ratio of 116.6% suggests the dividend is not fully covered by earnings. The average analyst target of $20.85 is below the current price of $21.38, implying limited upside. However, for patient investors who believe in the turnaround and can tolerate volatility, the stock could be a speculative buy near its 52-week low. The key is to monitor whether revenue stabilizes and margins improve in the coming quarters.
CPB is more suitable for long-term investors with a horizon of 3-5 years, given the current turnaround phase. The stock is highly volatile (beta 0.019, but price swings are large) and has underperformed the market by 53% over the past year. Short-term trading is risky due to the uncertain fundamental outlook and potential index removal. For long-term investors, the 7% dividend yield provides income while waiting for the turnaround to play out, but they must be prepared for further downside. A minimum holding period of 3 years is recommended to allow time for cost cuts and margin repair to show results.
